These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25844060)

  • 1. The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients.
    Klinzing S; Brandi G; Stehberger PA; Raptis DA; Béchir M
    BMC Anesthesiol; 2014; 14():103. PubMed ID: 25844060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic evaluation of patients undergoing living-donor liver transplant by APACHE II and MELD scores.
    Zhang ZY; Chen R; Zhou ZQ; Peng CH; Zhou GW
    Exp Clin Transplant; 2015 Feb; 13(1):41-5. PubMed ID: 24779711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.
    Oberkofler CE; Dutkowski P; Stocker R; Schuepbach RA; Stover JF; Clavien PA; Béchir M
    Crit Care; 2010; 14(3):R117. PubMed ID: 20550662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients.
    Inal MT; Memiş D; Kargi M; Sut N
    J Crit Care; 2009 Sep; 24(3):329-34. PubMed ID: 19327336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À; Mas A; Fernández J; García-Valdecasas JC
    Transplant Proc; 2012; 44(6):1539-41. PubMed ID: 22841207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.
    Ecochard M; Boillot O; Guillaud O; Roman S; Adham M; Mion F; Dumortier J
    Clin Transplant; 2011; 25(5):755-65. PubMed ID: 21158918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE; Wagner D; Stadlbauer V; Palma S; Gurakuqi G; Kniepeiss D; Iberer F; Smolle KH; Haas J; Trauner M
    Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
    Yunhua T; Weiqiang J; Maogen C; Sai Y; Zhiheng Z; Dongping W; Zhiyong G; Xiaoshun H
    J Clin Monit Comput; 2018 Jun; 32(3):471-479. PubMed ID: 28831767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Transplantation in Recipients With High Model for End-stage Liver Disease Score.
    González Martínez S; Molina Raya A; Becerra Massare A; Muffak Granero K; Villegas Herrera T; Villar Del Moral JM; Fundora Suárez Y
    Transplant Proc; 2018 Mar; 50(2):595-597. PubMed ID: 29579862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of enzymatic liver function for the estimation of short-term survival of liver transplant candidates: a prospective study with the LiMAx test.
    Jara M; Malinowski M; Lüttgert K; Schott E; Neuhaus P; Stockmann M
    Transpl Int; 2015 Jan; 28(1):52-8. PubMed ID: 25263095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of Prolonged ICU Stay in Liver Transplant Recipients in a Single-Center Experience.
    Niewińsk G; Raszeja-Wyszomirska J; Główczyńska R; Figiel W; Zając K; Kornasiewicz O; Zieniewicz K; Grąt M
    Transplant Proc; 2018 Sep; 50(7):2014-2017. PubMed ID: 30177100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
    Zipprich A; Kuss O; Rogowski S; Kleber G; Lotterer E; Seufferlein T; Fleig WE; Dollinger MM
    Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.
    Levesque E; Saliba F; Benhamida S; Ichaï P; Azoulay D; Adam R; Castaing D; Samuel D
    Liver Transpl; 2009 Oct; 15(10):1358-64. PubMed ID: 19790157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation.
    Olmedilla L; Lisbona CJ; Pérez-Peña JM; López-Baena JA; Garutti I; Salcedo M; Sanz J; Tisner M; Asencio JM; Fernández-Quero L; Bañares R
    Transplantation; 2016 Mar; 100(3):613-20. PubMed ID: 26569066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.
    Foxton MR; Al-Freah MA; Portal AJ; Sizer E; Bernal W; Auzinger G; Rela M; Wendon JA; Heaton ND; O'Grady JG; Heneghan MA
    Liver Transpl; 2010 May; 16(5):668-77. PubMed ID: 20440776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the predictive value of the model for end-stage liver disease scoring system combined with the indocyanine green clearance test for short-term prognosis of acute-on-chronic hepatitis B liver failure].
    Tang K; Shan J; Tian F; Cao W
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):190-4. PubMed ID: 24824120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.